The following meeting highlights are from the Perspectives in Melanoma XII conference, held in Scheveningen/The Hague, the Netherlands, on October 2-4, 2008. Selected reviews are included but further discussions of these and other presentations are posted at

Additional Metadata
Keywords agatolimod, alpha interferon, alpha2b interferon, anthracycline, antineoplastic agent, as 15, aso 2b, bms 663513, cancer antibody, carboplatin, cd40 antibody agonist, cp 870893, cytokine, cytotoxic T lymphocyte antigen 4 antibody, dacarbazine, granulocyte macrophage colony stimulating factor, immunoglobulin G antibody, ipilimumab, mdx 1106, melanoma antigen 3, monoclonal antibody, paclitaxel, peginterferon, protein Nodal, serum amyloid A, sorafenib, temozolomide, ticilimumab, toll like receptor agonist, unclassified drug
Persistent URL,
Journal Pigment Cell & Melanoma Research
Kirkwood, J.M, & Eggermont, A.M.M. (2009). Highlights from the perspectives in melanoma XII conference. Pigment Cell & Melanoma Research, 22(2), 156–165. doi:10.1111/j.1755-148X.2009.00555.x